Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

(NQ: )

N/A UNCHANGED
Last Price Updated: Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about

< Previous 1 2 3 Next >
OpGen Reports First Quarter 2018 Financial Results and Provides a Business Update
OpGen, Inc. (NASDAQ:OPGN) today reported financial and operating results for the three months ended March 31, 2018, and provided a summary of recent business highlights. Total revenue for the first... 
From GlobeNewswire News Releases
OpGen Announces Date of First Quarter 2018 Financial Results Conference Call
OpGen, Inc. (NASDAQ:OPGN) announced today that the Company will report financial results for the three months ended March 31, 2018 after close of the U.S. financial markets on Tuesday, May 8, 2018.... 
From GlobeNewswire News Releases
OpGen Highlights Acuitas® Analytical Validation Data for Rapidly Predicting Antibiotic Resistance Using Drug Resistance Gene Profiles at ECCMID
DNA Sequencing prediction results and evaluation of Acuitas Resistome Test for infection control presented 
From GlobeNewswire News Releases
OpGen Reports Fourth Quarter and Full Year 2017 Financial Results and Provides a Business Update
OpGen, Inc. (NASDAQ:OPGN) today reported financial and operating results for the three and 12 months ended December 31, 2017, and provided a summary of recent business highlights. Total revenue for the... 
From GlobeNewswire News Releases
OpGen Announces Date of Fourth Quarter and Fiscal Year 2017 Financial Results Conference Call
OpGen, Inc. (NASDAQ:OPGN) announced today that the Company will report its fourth quarter and fiscal year 2017 financial results after close of market on Thursday, March 15, 2018. OpGen’s management... 
From GlobeNewswire News Releases
OpGen to Present at the Cowen and Company 38th Annual Health Care Conference
OpGen, Inc. (NASDAQ:OPGN) announced today that Evan Jones, Chairman and Chief Executive Officer of the Company, will present a corporate overview at the Cowen and Company 38th Annual Health Care... 
From GlobeNewswire News Releases
OpGen Strengthens Supplier Relationship to Use Industry-Leading Real-Time PCR Technology for New Acuitas® Tests
Test rapidly detects 47 antimicrobial resistance markers directly from urine and bacterial isolates 
From GlobeNewswire News Releases
OpGen Announces Execution of Reverse Stock Split
OpGen, Inc. (NASDAQ:OPGN) announced today that it will implement a 1-for-25 reverse stock split of its common stock. The Company filed an amendment to its Certificate of Incorporation to effect the... 
From GlobeNewswire News Releases
Stock Review for Medical Research's Investors -- HTG Molecular Diagnostics, OpGen, Sorrento Tech, and DexCom
In keeping with the commitment to dynamically provide members with timely information, WallStEquities.com has issued free tailored Stock Review on HTGM, OPGN, ROKA, and DXCM which is a click away at... 
From PR Newswire
OpGen Reports 2017 Third Quarter Financial Results and Provides Business Update
OpGen, Inc. (NASDAQ:OPGN) reports financial and operational results for the three and nine months ended September 30, 2017, and provides a summary of recent business highlights. 
From GlobeNewswire News Releases
Daily Technical Summary Reports on Medical Research Stocks -- Exact Sciences, HTG Molecular Diagnostics, Roka Bioscience, and OpGen
From PR Newswire
OpGen Announces Date of Third Quarter 2017 Financial Results Conference Call
OpGen, Inc. (NASDAQ:OPGN) today announced that it will report its third quarter 2017 financial results after close of market on Tuesday, November 7, 2017. OpGen’s management team will host a live... 
From GlobeNewswire News Releases
OpGen Awarded CDC Contract to Develop Clinical Support Tools for Antimicrobial Stewardship and Infection Control
OpGen, Inc. (NASDAQ:OPGN) today announced that it has been awarded a contract from the Centers for Disease Control and Prevention (CDC) to develop smartphone-based clinical decision support solutions... 
From GlobeNewswire News Releases
OpGen to Present at Dawson James Securities 3rd Annual Small Cap Growth Conference
OpGen, Inc. (NASDAQ:OPGN) today announced that Evan Jones, the Company’s Chairman and Chief Executive Officer, will present a corporate overview at the Dawson James Securities 3rd Annual Small Cap... 
From GlobeNewswire News Releases
Medical Research Stock Performance Review -- OpGen, TearLab, TrovaGene, and PRA Health Sciences
From PR Newswire
OpGen to Present at the Ladenburg Thalmann 2017 Healthcare Conference
OpGen, Inc. (NASDAQ:OPGN) today announced that Evan Jones, the Company’s Chairman and Chief Executive Officer, will present a corporate overview at the Ladenburg Thalmann 2017 Healthcare Conference on... 
From GlobeNewswire News Releases
OpGen Data on New Rapid Gene Test and Antibiotic Susceptibility Prediction Algorithms Presented at the 2017 ASM/ESCMID Conference
OpGen, Inc. (NASDAQ:OPGN) today announced that the Company presented study results on the company’s new rapid test in development, the Acuitas® AMR Gene Panel u5.47, and the Acuitas Lighthouse®... 
From GlobeNewswire News Releases
OpGen to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
OpGen, Inc. (NASDAQ:OPGN) today announced that Evan Jones, the Company’s Chairman and Chief Executive Officer, will present a corporate overview at the Rodman & Renshaw 19th Annual Global Investment... 
From GlobeNewswire News Releases
Technical Reports on Medical Research Equities -- OpGen, TearLab, TrovaGene, and PRA Health Sciences
From PR Newswire
OpGen Reports 2017 Second Quarter Financial Results and Provides Business Update
OpGen, Inc. (NASDAQ:OPGN) reports financial and operational results for the three and six months ended June 30, 2017, and provides a summary of recent business highlights. 
From GlobeNewswire News Releases
Investor Network: OpGen, Inc. to Host Earnings Call
From ACCESSWIRE
OpGen Announces Date of Second Quarter 2017 Financial Results Conference Call
OpGen, Inc. (NASDAQ:OPGN) today announced that it will report its second quarter 2017 financial results after close of market on Tuesday, August 8, 2017. OpGen’s management team will host a live... 
From GlobeNewswire News Releases
OpGen Announces Closing of $10 Million Public Offering
OpGen, Inc. (NASDAQ:OPGN) announces the closing of its previously announced public offering of 18,164,195 units at $0.40 per unit, and 6,835,805 pre-funded units at $0.39 per pre-funded unit, raising... 
From GlobeNewswire News Releases
OpGen Announces Pricing of $10.0 Million Public Offering
OpGen, Inc. (NASDAQ:OPGN) announces the pricing of a public offering of an aggregate of 25,000,000 units. Each unit is comprised of one share of common stock (or common stock equivalent) and one common... 
From GlobeNewswire News Releases
OpGen Acuitas® MDRO Gene Test Approved by NY State Department of Health
OpGen, Inc. (NASDAQ:OPGN) announced today that the New York State Department of Health (NYSDOH) has approved the Acuitas® MDRO Gene Test for use by physicians and healthcare providers in the state. The... 
From GlobeNewswire News Releases
OpGen Signs Supply Agreement to Use Thermo Fisher Scientific’s Technology to Advance Acuitas® Rapid Test
OpGen, Inc. (NASDAQ:OPGN) announced today that it has entered into a global supply agreement to use Thermo Fisher Scientific’s technology to support the commercialization of its rapid molecular... 
From GlobeNewswire News Releases
OpGen’s Acuitas® Detection Technology Utilized in Publication Revealing Prevalence of CRE in Washington D.C. Healthcare Facilities
Results of over 1,000 patient samples for antibiotic resistant bacteria published today in Infection Control & Hospital Epidemiology 
From GlobeNewswire News Releases
OpGen Data at ASM Microbe 2017 Demonstrates Potential of Acuitas Products for Predicting Antibiotic Susceptibility and Infection Control
OpGen, Inc. (NASDAQ:OPGN) today announced the results from additional studies supporting the capabilities of its Acuitas Rapid Test and Acuitas Whole Genome Sequence Analysis to accurately predict... 
From GlobeNewswire News Releases
OpGen to Receive Ignaz Semmelweis Award for Commitment to Combatting Infection Deaths
OpGen, Inc. (NASDAQ:OPGN) announced today that they will be recognized with the 2nd annual Ignaz Semmelweis Award for their commitment to safe medical care through the development of rapid diagnostics... 
From GlobeNewswire News Releases
OpGen to Present Advancements in Antibiotic Susceptibility and Whole Genome Sequencing at ASM Microbe 2017
OpGen, Inc. (NASDAQ:OPGN) today announced that data on its Acuitas® Rapid Test in development and Acuitas Whole Genome Sequence Analysis will be presented at ASM Microbe 2017 being held June 1-5, 2017... 
From GlobeNewswire News Releases
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.